Skip to main content

 Scientific publications

SMAD4 Mutation in Small Cell Transformation of Epidermal Growth Factor Receptor Mutated Lung Adenocarcinoma.

Authors : DHaene N, Le Mercier M, Salmon I, Mekinda Z, Remmelink M, Berghmans T
Year : 2019
Journal : Oncologist
Volume : 24
Pages : 9-13

Definition of synchronous oligo-metastatic non-small cell lung cancer - a consensus report.

Authors : Dingemans AC, Hendriks LEL, Berghmans T, Levy A, Hasan B, Faivre-Finn C, Giaj-Levra M, Giaj-Levra N, Girard N, Greillier L, Lantuéjoul S, Edwards J, OBrien M, Reck M, Smit EF, van Schil P, Postmus PE, Ramella S, Lievens Y, Gaga M, Peled N, Scagliotti GV, Senan S, Paz-Ares L, Guckenberger M, McDonald F, Ekman S, Cufer T, Gietema H, Infante M, Dziadziuszko R, Peters S, Porta RR, Vansteenkiste J, Dooms C, De Ruysscher D, Besse B, Novello S
Year : 2019
Journal : J Thorac Oncol

[Lung transplantation for lepidic invasive adenocarcinoma: From a clinical question to an ethical consideration].

Authors : Créquit P, Cadranel J, Mal H, Grigoriu B, Berghmans T
Year : 2019
Journal : Rev Mal Respir
Volume : 36
Pages : 919-923

Current management of limited-stage SCLC and CONVERT trial impact: Results of the EORTC Lung Cancer Group survey.

Authors : Levy A, Hendriks LEL, Le Péchoux C, Falk S, Besse B, Novello S, Dingemans AC, Hasan B, Reck M, Berghmans T, Faivre-Finn C
Year : 2019
Journal : Lung Cancer
Volume : 136
Pages : 145-147

The Position of Inhaled Chemotherapy in the Care of Patients with Lung Tumors: Clinical Feasibility and Indications According to Recent Pharmaceutical Progresses.

Authors : Rosière R, Berghmans T, de Vuyst P, Amighi K, Wauthoz N
Year : 2019
Journal : Cancers (Basel)
Volume : 11

[Lung cancer: Prognosis in intensive care depends mainly on the acute complication].

Authors : Gorham J, Ameye L, Paesmans M, Berghmans T, Sculier JP, Meert AP
Year : 2019
Journal : Rev Mal Respir
Volume : 36
Pages : 333-341

Defining synchronous oligometastatic non-small cell lung cancer: a systematic review.

Authors : GiajLevra N, Levra MG, Durieux V, Novello S, Besse B, Hasan B, Hendriks LE, Levy A, Dingemans AC, Berghmans T
Year : 2019
Journal : J Thorac Oncol

Defining oligometastatic non-small cell lung cancer: A simulated multidisciplinary expert opinion.

Authors : Hendriks LEL, Dooms C, Berghmans T, Novello S, Levy A, De Ruysscher D, Hasan B, Giaj Levra M, Giaj Levra N, Besse B, Vansteenkiste J, Dingemans AC
Year : 2019
Journal : Eur J Cancer
Volume : 123
Pages : 28-35

EORTC Lung Cancer Group survey on the definition of NSCLC synchronous oligometastatic disease.

Authors : Levy A, Hendriks LEL, Berghmans T, Faivre-Finn C, GiajLevra M, GiajLevra N, Hasan B, Pochesci A, Girard N, Greillier L, Lantuéjoul S, Edwards J, OBrien M, Reck M, Besse B, Novello S, Dingemans AC
Year : 2019
Journal : Eur J Cancer
Volume : 122
Pages : 109-114

Evolution and revolution in systemic treatment of lung cancer. The new role of immunotherapy.

Authors : Duruisseaux M, Berghmans T
Year : 2018
Journal : Rev Mal Respir
Volume : 35
Pages : 101-102

Une nouvelle étoile au firmament scientifique.

Authors : Berghmans T
Year : 2018
Journal : Rev Med Brux
Volume : 39
Pages : 68

Diversity of brain metastases screening and management in non-small cell lung cancer in Europe: Results of the European Organisation for Research and Treatment of Cancer Lung Cancer Group survey.

Authors : Levy A, Faivre-Finn C, Hasan B, De Maio E, Berghoff AS, Girard N, Greillier L, Lantuéjoul S, OBrien M, Reck M, Dingemans AC, Novello S, Berghmans T, Besse B, Hendriks L
Year : 2018
Journal : Eur J Cancer
Volume : 93
Pages : 37-46

Immune checkpoint inhibitors (antibodies to PD1 and PD-L1), a new therapeutic weapon against non-small cell bronchial carcinoma.

Authors : Berghmans T, Grigoriu B, Sculier JP, Meert AP
Year : 2018
Journal : Rev Mal Respir
Volume : 35(2)
Pages : 197-205

Immunotherapy: a new standard of care in thoracic malignancies? A summary of the European Respiratory Society research seminar of the Thoracic Oncology Assembly.

Authors : Costantini A, Grynovska M, Lucibello F, Moisés J, Pagès F, Tsao MS, Shepherd FA, Bouchaab H, Garassino M, Aerts JGJV, Mazières J, Mondini M, Berghmans T, Meert AP, Cadranel J
Year : 2018
Journal : Eur Respir J
Volume : 51

Impact of routine brain imaging in the initial management of lung cancer.

Authors : Niviere P, Sculier JP, Meert AP, Berghmans T
Year : 2018
Journal : Rev Mal Respir
Volume : 35
Pages : 55-61

A phase III randomised study comparing concomitant radiochemotherapy with cisplatin and docetaxel as induction versus consolidation treatment in patients with locally advanced unresectable non-small cell lung cancer.

Authors : Sculier JP, Lafitte JJ, Berghmans T, Meert AP, Scherpereel A, Roelandts M, Van Cutsem O, Colinet B, Bonduelle Y, Giner V, Paesmans M, Leclercq N, Van Houtte P
Year : 2018
Journal : Lung Cancer
Volume : 117
Pages : 32-37

Revue Médicale de Bruxelles : nouveautés et changement pour 2018.

Authors : Berghmans T
Year : 2018
Journal : Rev Med Brux
Volume : 39
Pages : 3

Le mot du Rédac-Chef.

Authors : Berghmans T
Year : 2018
Journal : Rev Med Brux
Volume : 39
Pages : 131

New drugs in thoracic oncology: needs and knowledge - an online ERS Lung Cancer Assembly survey.

Authors : Berghmans T, Evison M, Blum TG, Peled N, Cadranel J
Year : 2018
Journal : ERJ Open Res
Volume : 4

Current efforts in research of pleural mesothelioma-An analysis of the ClinicalTrials.gov registry.

Authors : Süveg K, Putora PM, Berghmans T, Glatzer M, Kovac V, Cihoric N
Year : 2018
Journal : Lung Cancer
Volume : 124
Pages : 12-18